Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Oclacitinib is dosed at 0.4–0.6 mg/kg PO q12h x 14 days, then q24h in dogs, per APOQUEL - Oclacitinib Maleate Tablet, Coated [US Product Label for Dogs]. Kalamazoo, MI: Zoetis Inc.; 2020. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a39a0298-6453-4c21-a3b0-01c1a52a109b — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.976 (2026-08-01).. Oclacitinib is used in dogs for Allergic/atopic dermatitis (pruritus control). Routes documented in dogs: PO. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Oclacitinib in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Apoquel
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| PO | 0.4–0.6 mg/kg | q12h x 14 days, then q24h | Long-term maintenance at q24h | Allergic/atopic dermatitis (pruritus control) | Strong | APOQUEL - Oclacitinib Maleate Tablet, Coated [US Product Label for Dogs]. Kalamazoo, MI: Zoetis Inc.; 2020. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a39a0298-6453-4c21-a3b0-01c1a52a109b — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.976 (2026-08-01). |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Selectively inhibits JAK1 (and to lesser extent JAK3), blocking signaling of itch and inflammation cytokines (IL-31, IL-4, IL-13) involved in allergic dermatitis.
Dogs only (not cats). Rapid onset of anti-pruritic effect (within 4h). Not for use under 12 months age. Immunosuppression risk — not recommended with concurrent immunosuppressives. May increase susceptibility to demodicosis and infections.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Oclacitinib dose range in dogs, with cited source references: PO 0.4–0.6 mg/kg q12h x 14 days, then q24h. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Oclacitinib in dogs: PO.
Cited course lengths for Oclacitinib in dogs include: Long-term maintenance at q24h. Duration depends on the indication — match it to the specific dose rule in the table above.
Oclacitinib is indicated in dogs for: Allergic/atopic dermatitis (pruritus control).
These are general warnings for Oclacitinib across species; consult the dog dosing table above for species-specific guidance. Dogs only (not cats). Rapid onset of anti-pruritic effect (within 4h). Not for use under 12 months age. Immunosuppression risk — not recommended with concurrent immunosuppressives. May increase susceptibility to demodicosis and infections.
Why a species-specific page? Oclacitinib pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.